For decades, family physicians in the United States have trusted the American Academy of Family Physicians (AAFP) to keep them up to date.
Board exams looming? There’s a CME module for that. New guidelines? AAFP has your back. The organization proudly brands its continuing medical
education as evidence-based, unbiased, and highly valued by family doctors everywhere.
That’s why it was so jarring when a Science-Based Medicine (SBM) article took aim at one of those very home study courses. In a detailed critique,
Harriet Hall, MD (“The SkepDoc”), described how an AAFP FP Essentials monograph on chronic pain management recommended a suite of
non–science-based treatments acupuncture, chiropractic manipulation, “touch therapy,” and S-adenosyl methionine (SAM-e)
as if they were firmly grounded in solid evidence.
The issue isn’t that these therapies are inherently evil, or that patients never feel better when they try them. The problem is subtler and far more
important: when a trusted organization blurs the line between strong evidence and wishful thinking, it undermines the very idea of
science-based medicine and the credibility of CME itself. This article unpacks the controversy, looks at what the science actually says,
and explores what it means for physicians and patients who rely on AAFP’s educational programs.
AAFP and Its Home Study Courses: Why They Matter
The AAFP is one of the largest national medical organizations, representing more than 100,000 family physicians, residents, and students across the United States.
It plays a central role in defining what “good” family medicine looks like, from residency training to lifelong learning. Its CME programs including journals,
live conferences, online courses, and home study modules are marketed as rigorously evidence-based.
Among these offerings is the FP Essentials series, a long-running set of monographs that aims to cover the core curriculum of family medicine
over a nine-year cycle. Each issue focuses on a specific topic and includes a self-assessment quiz for CME credit. For busy clinicians, FP Essentials can feel
like an educational lifeline: read the module, take the test, stay current, and keep your certification on track.
So when FP Essentials #432, covering chronic pain management, recommended several “integrative” and alternative treatments as if they were validated by strong
science, it raised a troubling question: is the evidence-based filter slipping?
What the Chronic Pain Module Recommended
According to the SBM critique, the FP Essentials module treated several controversial therapies as though they were on a par with conventional,
well-studied interventions. Specifically, it suggested chronic pain could be treated with:
- Acupuncture
- Chiropractic manipulation
- Touch therapy and “energy” treatments
- S-adenosyl methionine (SAM-e) supplements
These therapies were presented in a way that would reasonably lead a reader to think they’re supported by robust clinical evidence. The problem, as Hall points out,
is that when you look at the totality of the research including negative trials and higher-quality systematic reviews that picture falls apart.
Acupuncture: An “Elaborate Placebo”?
Acupuncture often gets star status in chronic pain discussions. The FP Essentials module highlighted it as a helpful option, implying that “acupuncture”
in general has been shown to relieve pain. But as Hall and many researchers note, that word hides a messy reality.
“Acupuncture” can mean needles, acupressure, electroacupuncture, moxibustion, cupping, or even variations like colorpuncture and tapping dolls with hammers.
Studies mix and match techniques, points, and protocols. When higher-quality trials use sham needles, toothpicks, or non-acupuncture points,
the results often show no meaningful difference between “real” and sham treatments. The effects are typically small, inconsistent, and
compatible with placebo and expectation effects rather than a specific physiological mechanism.
Systematic reviews and meta-analyses have reached conflicting conclusions, but when skeptically re-analyzed, many of the small “positive” effects shrink
toward clinical irrelevance. The overall evidence suggests that acupuncture’s benefits are, at best, modest and not clearly distinguishable from placebo.
That doesn’t mean patients never feel better it means the benefit likely comes from non-specific effects like time, empathy, and ritual rather than
the placement of needles along mystical meridians.
Chiropractic Manipulation and Neck Pain
The FP Essentials module reportedly suggested that manipulation can help chronic neck pain, citing “weak evidence.” That’s a generous description.
Systematic reviews have generally found that spinal manipulation is no better than gentler mobilization techniques and that both are only helpful when
combined with exercise and physical therapy strategies, not as standalone miracle fixes.
More concerning, neck manipulation carries a small but real risk of serious complications, most notably vertebral artery dissection and stroke.
While the absolute risk is low, it is not zero and any honest discussion of cervical manipulation in an evidence-based CME module should include
that warning. Leaving out the risk while overselling the benefit is the educational equivalent of burying the side effects in eight-point font.
Touch Therapy and the Mythical “Human Energy Field”
Touch therapy, healing touch, therapeutic touch, Reiki these practices all revolve around manipulating a supposed “human energy field” with the hands.
The FP Essentials module described these as options for chronic pain, citing outdated or withdrawn reviews and giving the impression of scientific legitimacy.
The problem is straightforward: this “energy field” has never been demonstrated to exist. We can measure incredibly small electromagnetic and
subatomic phenomena, yet no instrument has credibly detected the subtle biofield that practitioners claim to sense and manipulate.
When therapies rest on entities that can’t be detected or defined, we’re no longer in the realm of science; we’re in the realm of belief.
One famous experiment, done as a school science fair project and later published in a major medical journal, tested whether experienced therapeutic touch
practitioners could sense a hand’s “energy field” when they couldn’t see it. They guessed no better than chance. It was a devastatingly simple demonstration
that the emperor’s new energy field might be nothing more than a story we tell ourselves.
SAM-e: Interesting, But Not a General Pain Cure
SAM-e (S-adenosyl methionine) is a compound naturally involved in methylation reactions in the body, often sold as a dietary supplement.
Some studies suggest it may help osteoarthritis symptoms, and evidence-based databases sometimes rate it as “likely effective” for that specific condition
and “possibly effective” for a few others.
But that’s a far cry from recommending SAM-e broadly for “chronic pain.” Larger, better trials are limited. Systematic reviews point out small,
inconsistent benefits and significant uncertainty. Some authoritative sources explicitly caution against using SAM-e to replace conventional therapies,
and they call for more robust research before routine clinical use.
Presenting SAM-e as a general chronic pain treatment in a CME module without clearly communicating the limited evidence, narrow indications,
and unknown long-term risks gives clinicians a misleading impression of how strong the data really are.
Why Science-Based Medicine Pushed Back
The Science-Based Medicine critique isn’t a random blog rant. It fits into a broader conversation about what counts as
evidence-based medicine (EBM) and how CME should handle therapies that live on the border between science and speculation.
Modern EBM emphasizes:
- Using the best available evidence, not just some evidence.
- Weighing systematic reviews and high-quality trials more heavily than small, poorly controlled studies.
- Looking at the totality of data, including negative or neutral trials.
- Integrating evidence with clinical judgment and patient values but not replacing evidence with personal anecdotes.
The SBM article argues that the FP Essentials module violated several of these principles. It cherry-picked positive trials,
ignored conflicting systematic reviews, and downplayed serious conceptual and safety concerns. In other words, it treated
some evidence as if it were good evidence and blurred the line between plausible adjuncts and theatrical placebos.
For a major professional organization that explicitly promises evidence-based CME, that’s not just an editorial oops.
It risks normalizing pseudoscience in mainstream medicine and confusing physicians about where the scientific bar should be set.
How Non–Science-Based Treatments Sneak into CME
If the AAFP prides itself on evidence-based CME, how do non–science-based treatments still find their way into home study modules?
Several forces push in that direction:
-
Patient demand: Many patients already use complementary and alternative medicine. CME authors may feel pressure
to “meet patients where they are” by mentioning popular therapies, even when the evidence is weak. -
Integrative medicine branding: The rise of “integrative” programs in academic and community settings has blurred
the boundary between science-based care and speculative add-ons. Clinicians may assume that if something is labeled “integrative,”
it must have solid evidence behind it. -
Fragmented evidence: With thousands of journals and millions of papers, it’s always possible to find a few positive
trials if you’re motivated enough even for therapies that fail when rigorously tested. -
CME economics and marketing: Some CME activities are influenced by sponsors or by marketability.
“New” and “holistic” sometimes sell better than “boring but proven.”
Add in time pressure on busy authors and editors, and it’s not hard to see how modules can slip from “carefully curated evidence”
into “optimistic cherry-picking with nice graphics.”
The Ethical Problem: Teaching Unproven Therapies as If They Work
Ethically, CME providers have a clear responsibility: don’t teach clinicians to do things that are unsupported or contradicted by
good evidence, especially when those things carry real risks or opportunity costs. When a respected organization blurs that line,
several problems emerge:
- Patient trust: Patients assume doctors’ recommendations are grounded in science, not marketing or wishful thinking.
- Resource waste: Time and money spent on unproven therapies could be redirected to interventions that actually help.
-
Professional confusion: Mixed messages in CME make it harder for clinicians to distinguish solid evidence
from noise. That confusion trickles down into everyday practice.
None of this means physicians must reject every unconventional modality outright. But if a therapy is still in the realm of
experimental or placebo-level benefit, CME should clearly say so, not dress it up as established best practice.
What a Truly Evidence-Based Pain Module Could Look Like
A chronic pain module that fully embraces science-based medicine would:
- Emphasize multidisciplinary care: physical therapy, gradual exercise, sleep optimization, and behavioral strategies.
- Highlight psychological interventions like cognitive behavioral therapy and pain coping skills, which have stronger evidence than many “integrative” add-ons.
- Discuss pharmacologic options with nuance: non-opioid analgesics, cautious use of opioids when necessary, and realistic expectations about benefits and risks.
- Address comorbidities such as depression, anxiety, and substance use, which shape pain experience and outcomes.
- Frame any unconventional therapies explicitly as experimental or adjunctive, with honest communication about weak or inconsistent evidence.
In short, a science-based module would not forbid curiosity about new or unconventional approaches. But it would keep them in their
proper place on the evidence ladder, clearly labeled and honestly explained.
How Clinicians and Patients Can Respond
So what can you do if you’re a clinician reading a CME module that seems a bit… enthusiastic about questionable therapies?
-
Look for the hierarchy of evidence. Are recommendations based on large randomized trials and systematic reviews,
or on small, poorly controlled studies? - Watch for cherry-picking. If a module cites only positive studies without acknowledging conflicting data, that’s a red flag.
-
Beware of mysterious mechanisms. If a treatment rests on poorly defined “energy fields” or vaguely described forces,
ask whether those concepts have ever been empirically verified. -
Talk openly with patients. If your patient uses or asks about alternative treatments, respond with curiosity, respect,
and clear information about what we do and don’t know.
For patients, the advice is similar: ask what kind of evidence backs a recommendation. “I’ve seen it work” is not the same as
“rigorous trials show a meaningful benefit.” It’s okay to be politely skeptical good clinicians should welcome those questions.
Real-World Experiences with Non–Science-Based CME
To understand why this issue matters beyond a single SBM blog post, imagine the lived experience of a typical family physician navigating CME.
Dr. Lopez is a mid-career family physician in a small town. Between a full schedule of patients, charting, prior authorizations, and
the occasional late-night call, her “free time” is basically a rumor. Like many colleagues, she relies heavily on home study modules
and online CME to keep up with new evidence and meet certification requirements.
One weekend, she sits down with a chronic pain management module. She expects the usual: updated guidelines on NSAIDs and opioids,
maybe a new paper on neuropathic pain therapies, and a reminder about multimodal treatment. Instead, she finds glowing language about
acupuncture and touch therapy and a table suggesting SAM-e as a chronic pain option, listed alongside conventional treatments with no
clear visual distinction in strength of evidence.
At first glance, it looks reassuring. “Recommended,” “effective,” and “beneficial” are powerful words in the CME context.
Dr. Lopez remembers a couple of grateful patients who swore acupuncture changed their lives. She also knows her clinic is under pressure
to reduce opioid prescribing. The idea of a needle-based, side-effect-light option sounds tempting.
But she pauses. Over the past few years, she’s read more critical takes on alternative medicine, including SBM-style analyses and
skeptical reviews of acupuncture and energy therapies. She decides to dig a little deeper. The module cites a few small trials with
modest benefits, but it doesn’t mention larger, better-controlled studies that show no clinically significant difference from sham treatments.
It doesn’t touch the debate about acupuncture’s mechanism or the possibility that its apparent benefits are mostly placebo effects wrapped in
ritual and expectation.
Curious and a bit uneasy she brings the module to her next journal club. Her colleagues have had similar experiences. One remembers a
CME talk that implied “detox” protocols could help everything from fatigue to chronic pain. Another recalls a webinar where the presenter
casually recommended supplements for vague inflammatory symptoms, with slides that looked suspiciously like a product catalog.
Together, they start treating CME content the way they treat any clinical question: by checking the primary literature, looking up independent
evidence summaries, and comparing multiple sources. They discover that some of the most glowing claims in their CME materials are based on thin
or cherry-picked evidence, while stronger systematic reviews are either downplayed or ignored.
The result isn’t that they swear off every unconventional therapy forever. Instead, they learn to re-label them in their minds.
Acupuncture becomes “a theatrical placebo with weak evidence for small, short-term pain relief in some contexts.” Touch therapy becomes “a ritual
practice with no demonstrated underlying energy mechanism and no robust evidence of specific benefit.” SAM-e becomes “a supplement with limited data
for osteoarthritis, not a general-purpose chronic pain drug.”
Most importantly, they begin to see CME not as sacred text but as another information source that must earn their trust.
When a module is transparent about uncertainty and clearly distinguishes hypotheses from established practice, their trust goes up.
When it glosses over controversies or omits negative data, their trust goes down.
For organizations like the AAFP, this evolving mindset among clinicians is both a challenge and an opportunity. It means doctors are more likely
to spot weak arguments and push back when CME drifts into pseudoscience. But it also means that maintaining credibility now requires
absolute clarity: if a treatment’s evidence is shaky, say so. If it’s mostly placebo, say that too. If it’s promising but unproven, invite
curious, honest discussion rather than marketing language.
The AAFP’s chronic pain module controversy is more than a one-off embarrassment. It’s a case study in how easy it is for an evidence-based brand
to slip into promotional territory and how essential it is for clinicians, educators, and skeptical voices like Science-Based Medicine
to keep asking the uncomfortable question: “Does the evidence really support this, or are we just hoping it does?”
Conclusion: Demanding Better from Family Medicine
Chronic pain is hard. Patients are desperate for relief, and clinicians are desperate for tools that work without causing harm.
That understandable desperation makes the medical community especially vulnerable to overselling “integrative” and alternative treatments
that sound scientific but don’t stand up to rigorous scrutiny.
The AAFP is right to emphasize evidence-based education and to explore new approaches to complex problems like chronic pain.
But when a home study course recommends non–science-based treatments as if they are supported by strong evidence, it betrays that mission.
Science-Based Medicine’s critique isn’t an attack on family medicine; it’s a reminder of what evidence-based CME should look like.
In the end, both clinicians and patients are better served when professional organizations hold their own materials to the same standards
they expect from everyone else: skeptical, transparent, and relentlessly honest about where the evidence ends and speculation begins.
